The FDA has accepted the NDA for zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.

Explore how evolving tools and emerging pathogens are reshaping the diagnosis and treatment of Pelvic Inflammatory Disease.